GlassScriptPhysician profile
Brian Joseph Burger
NPI 1184143406
$964.42
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $346 · 2022: $505 · 2023: $30.69 · 2024: $82.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $113.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $148.01 | 2021 | |
| Genzyme Corporation | $137.23 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $100.50 | 2022 | |
| Jazz Pharmaceuticals INC. | $82.37 | 2024 | |
| Amneal Pharmaceuticals LLC | $75.29 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $70.67 | 2021-2022 | |
| Amgen INC. | $63.08 | 2021-2022 | |
| Abbvie INC. | $57.82 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $42.36 | 2022 | |
| Supernus Pharmaceuticals, INC. | $35.64 | 2022 | |
| Emd Serono, INC. | $34.60 | 2022 | |
| Lilly USA, LLC | $25.61 | 2021-2022 | |
| Eisai INC. | $16.85 | 2021 | |
| Cala Health, INC. | $16.60 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $15.67 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $14.84 | 2021 | |
| Acadia Pharmaceuticals INC | $13.76 | 2022 | |
| Sk Life Science, INC. | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Burger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.